Category Archives: Biomaterials

Advantages of soft subdural implants for the delivery of electrochemical neuromodulation therapies to the spinal cord.

Journal of Neural Engineering Abstract: OBJECTIVE: We recently developed soft neural interfaces enabling the delivery of electrical and chemical stimulation to the spinal cord. These stimulations restored locomotion in animal models of paralysis. Soft interfaces can be placed either below … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Neuroscience Abstracts, Rehabilitation | Tagged , , , , , , , , , | 1 Comment

A computational model of epidural electrical stimulation of the cervical spinal cord in non-human primates

Abstract: Cervical spinal cord injury alters the communication between the brain and the spinal circuits controlling movement, often leading to tetraplegia. Epidural Electrical Stimulation (EES) of the lumbar spinal cord has shown promising results to restore leg motor control after … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Neuroscience Abstracts, Rehabilitation, Spinal Research | 1 Comment

Development of an intraneural peripheral stimulation paradigm for reversing hand paralysis in non-human primates

Regaining the capacity to grasp and manipulate objects is of crucial importance to people living with upper limb paralysis. Functional electrical stimulation of forearm muscles has been used to reanimate paralyzed muscles. However, complex setups requiring multiple muscles to be … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Neuroscience Abstracts, Rehabilitation, Spinal Research

Fortuna Fix Announces Series B Financing, Adding Amgen Ventures and Macnguyen Family Office as Shareholders

(Newswire.com) Press Release: November 8, 2017 Fortuna Fix – Fortuna Fix (“Fortuna”), a private, clinical-stage Regenerative Medicine company is aiming to be the first to bring to the clinic a patient’s own neural stem cells (autologous) produced by direct reprogramming … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

InVivo Therapeutics restructures and suspends chronic SCI stem cell and gene therapy research programs

CAMBRIDGE, Mass. (August 28, 2017) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that it is executing a strategic restructuring in order to focus on The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Spinal Research, Stem Cell Research | Tagged | 2 Comments

Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board

Montreal, Canada, May 4, 2017 (Newswire.com) – Fortuna Fix Inc. (“Fortuna”), a private, clinical-stage biotech company, is aiming to be the first to eliminate the need for embryonic and fetal stem cells by using direct reprogramming of autologous cells to treat … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, Spinal Research, Stem Cell Research, Unite 2 Fight Paralysis | Tagged , , , , | 1 Comment

Stretching the boundaries of neural implants

Rubbery, multifunctional fibers could be used to study spinal cord neurons and potentially restore function. David L. Chandler | MIT News Office Implantable fibers have been an enormous boon to brain research, allowing scientists to stimulate specific targets in the … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research

Working 2 Walk 2016 Panel Discussion with Dr. Ann Parr and Dr. Alex Aimetti

The audience at the Working 2 Walk Symposium asks questions about the presentations of Dr. Parr and Dr. Aimetti. Alex Aimetti, PhD, is Senior Director, Medical Education and Scientific Support at InVivo Therapeutics. InVivo is a research and clinical-stage biomaterials … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium | Tagged , | 3 Comments

InVivo Therapeutics at Meeting on the Mesa

InVivo Therapeutics Video Presentation at Alliance for Regenerative Medicine 6th Annual Partnering Forum Tom Ulich, M.D., Chief Scientific Officer, Cambridge, MA (NASDAQ: NVIV)

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research | Tagged , ,

Translation of Biomaterial Based Therapies for Spinal Cord Injury – Dr. Alex Aimetti

Dr. Aimetti talks about the clinical and pre-clinical advancements made by InVivo Therapeutics to develop treatments for acute and chronic spinal cord injury. Alex Aimetti, PhD, is Senior Director, Medical Education and Scientific Support at InVivo Therapeutics. InVivo is a … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium | Tagged